Animal Models to Study Plaque Vulnerability
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
1013-1020
Author(s):
K. Schapira, S. Heeneman and M. J. A.P. Daemen
Carotid Artery Atherosclerosis: What is the Evidence for Drug Action?
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
1141-1159
Author(s):
Stella S. Daskalopoulou, Marios E. Daskalopoulos, Despina Perrea, Andrew N. Nicolaides and Christos D. Liapis
Demystifying the ACE Polymorphism: From Genetics to Biology
Journal:
Current Pharmaceutical Design
Volume:
13
Page:
1191-1198
Author(s):
Raquel Castellon and Hamdi K. Hamdi
Insights into Oxidative Stress: The Isoprostanes
Journal:
Current Medicinal Chemistry
Volume:
14
Page:
703-717
Author(s):
Paolo Montuschi, Peter Barnes and L. Jackson Roberts
CD40L - A Multipotent Molecule for Tumor Therapy
Journal:
Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume:
7
Page:
23-28
Author(s):
Angelica Loskog and Thomas H. Totterman
Leukocytes in Diabetic Retinopathy
Journal:
Current Diabetes Reviews
Volume:
3
Page:
3-14
Author(s):
Rakesh Chibber, Bahaedin M. Ben-Mahmud, Surina Chibber and Eva M. Kohner
Mass Spectrometric Analysis of F2-Isoprostanes: Markers and Mediators in Human Disease
Journal:
Current Pharmaceutical Analysis
Volume:
3
Page:
39-51
Author(s):
Edzard Schwedhelm, Ralf A. Benndorf, Rainer H. Boger and Dimitrios Tsikas
Development of Tissue Engineered Vascular Grafts
Journal:
Current Pharmaceutical Biotechnology
Volume:
8
Page:
43-50
Author(s):
G. R. Campbell and J. H. Campbell
Molecular Targets in Osteoarthritis: Metalloproteinases and Their Inhibitors
Journal:
Current Drug Targets
Volume:
8
Page:
293-303
Author(s):
P. S. Burrage and C. E. Brinckerhoff
Targeting Strategies to Modulate the NF-κB and JNK Signal Transduction Network
Journal:
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Volume:
6
Page:
71-84
Author(s):
Michael Kracht